Inhibitory Effect of Oral Doxycycline on Neovascularization in a Rat Corneal Alkali Burn Model of Angiogenesis

REFERENCES

• Chang J H, Gabison E E, Kato T, Azar D T. Corneal neovascularization. Curr Opin Ophthalmol. 2001; 12(4)242–249
   PubMed Web of Science ®Google Scholar
• Yamada J, Dana M R, Sotozono C, Kinoshita S. Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury. Exp Eye Res. 2003; 76(2)161–167
   PubMed Web of Science ®Google Scholar
• Dana M R, Zhu S N, Yamada J. Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea. 1998; 17(4)403–409
   PubMed Web of Science ®Google Scholar
• Demir T, Turgut B, Celiker U, Ozercan I, Ulas F, Akyol N. Effects of octreotide acetate and amniotic membrane on wound healing in experimental glaucoma surgery. Doc Ophthalmol. 2003; 107(2)87–92
   PubMed Web of Science ®Google Scholar
• Benelli U, Ross J R, Nardi M, Klintworth G K. Corneal neovascularization induced by xenografts or chemical cautery. Inhibition by cyclosporin A. Invest Ophthalmol Vis Sci. 1997; 38(2)274–282
   PubMed Web of Science ®Google Scholar
• Benelli U, Lepri A, Del T M, Nardi M. FK-506 delays corneal graft rejection in a model of corneal xenotransplantation. J Ocul Pharmacol Ther. 1996; 12(4)425–431
   PubMed Web of Science ®Google Scholar
• Kim J H, Kim J C, Shin S H, Chang S I, Lee H S, Chung S I. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF. Exp Mol Med. 1999; 31(4)203–209
   PubMed Web of Science ®Google Scholar
• Klauber N, Browne F, Apte B, D'Amato R J. New activity of spironolactone. Inhibition of angiogenesis in vitro in vivo. Circulation. 1996; 94(10)2566–2571
   PubMed Web of Science ®Google Scholar
• Kenyon B M, Browne F, D'Amato R J. Effects of thalidomide and related metabolites in a mouse corneal model of neovascularization. Exp Eye Res. 1997; 64(6)971–978
   PubMed Web of Science ®Google Scholar
• Sood A K, Gupta B, Chugh P. Topical amiloride accelerates healing and delays neovascularization in mechanically produced corneal ulcers in rabbits. Methods Find Exp Clin Pharmacol. 1999; 21(7)491–497
   PubMedGoogle Scholar
• Arbiser J L, Klauber N, Rohan R, et al. Curcumin is an in vivo inhibitor of angiogenesis. Mol Med. 1998; 4(6)376–383
   PubMed Web of Science ®Google Scholar
• Cohen R A, Gebhardt B M, Bazan N G. A platelet-activating factor antagonist reduces corneal allograft inflammation and neovascularization. Curr Eye Res. 1994; 13(2)139–144
   PubMed Web of Science ®Google Scholar
• Kwon Y S, Kim J C. Inhibition of corneal neovascularization by rapamycin. Exp Mol Med. 2006; 38(2)173–179
   PubMed Web of Science ®Google Scholar
• Kwon Y S, Hong H S, Kim J C, Shin J S, Son Y. Inhibitory effect of rapamycin on corneal neovascularization in vitro in vivo. Invest Ophthalmol Vis Sci. 2005; 46(2)454–460
   PubMed Web of Science ®Google Scholar
• Murata M, Takanami T, Shimizu S, et al. Inhibition of ocular angiogenesis by diced small interfering RNAs (siRNAs) specific to vascular endothelial growth factor (VEGF). Curr Eye Res. 2006; 31(2)171–180
   PubMed Web of Science ®Google Scholar
• Ma D H, Chen J K, Kim W S, et al. Expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in inflammation-induced corneal neovascularization. Ophthalmic Res. 2001; 33(6)353–362
   PubMed Web of Science ®Google Scholar
• Sounni N E, Janssen M, Foidart J M, Noel A. Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis. Matrix Biol. 2003; 22(1)55–61
   PubMed Web of Science ®Google Scholar
• Kvanta A, Sarman S, Fagerholm P, Seregard S, Steen B. Expression of matrix metalloproteinase-2 (MMP-2) and vascular endothelial growth factor (VEGF) in inflammation-associated corneal neovascularization. Exp Eye Res. 2000; 70(4)419–428
   PubMed Web of Science ®Google Scholar
• Brew K, Dinakarpandian D, Nagase H. Tissue inhibitors of metalloproteinases: Evolution, structure and function. Biochim Biophys Acta. 2000; 1477(1–2)267–283
   PubMed Web of Science ®Google Scholar
• Ma D H, Zhang F, Shi W, et al. Expression of tissue inhibitor of metalloproteinase-4 in normal human corneal cells and experimental corneal neovascularization. Ophthalmic Res. 2003; 35(4)199–207
   PubMed Web of Science ®Google Scholar
• Peterson J T. Matrix metalloproteinase inhibitor development and the remodeling of drug discovery. Heart Fail Rev. 2004; 9(1)63–79
   PubMed Web of Science ®Google Scholar
• Golub L M, Lee H M, Lehrer G, et al. Minocycline reduces gingival collagenolytic activity during diabetes. Preliminary observations and a proposed new mechanism of action. J Periodontal Res. 1983; 18(5)516–526
   PubMed Web of Science ®Google Scholar
• Guerin C, Laterra J, Masnyk T, Golub L M, Brem H. Selective endothelial growth inhibition by tetracyclines that inhibit collagenase. Biochem Biophys Res Commun. 1992; 188(2)740–745
   PubMed Web of Science ®Google Scholar
• Sapadin A N, Fleischmajer R. Tetracyclines: Nonantibiotic properties and their clinical implications. J Am Acad Dermatol. 2006; 54(2)258–265
   PubMed Web of Science ®Google Scholar
• Solomon A, Rosenblatt M, Li D Q, et al. Doxycycline inhibition of interleukin-1 in the corneal epithelium. Invest Ophthalmol Vis Sci. 2000; 41(9)2544–2557
   PubMed Web of Science ®Google Scholar
• Sobrin L, Liu Z, Monroy D C, et al. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci. 2000; 41(7)1703–1709
   PubMed Web of Science ®Google Scholar
• Dursun D, Kim M C, Solomon A, Pflugfelder S C. Treatment of recalcitrant recurrent corneal erosions with inhibitors of matrix metalloproteinase-9, doxycycline, and corticosteroids. Am J Ophthalmol. 2001; 132(1)8–13
   PubMed Web of Science ®Google Scholar
• Burns F R, Stack M S, Gray R D, Paterson C A. Inhibition of purified collagenase from alkali-burned rabbit corneas. Invest Ophthalmol Vis Sci. 1989; 30(7)1569–1575
   PubMed Web of Science ®Google Scholar
• Peyman G A, Kazi A A, Riazi-Esfahani M, Aydin E, Kivilcim M, Sanders D R. The effect of combinations of flurbiprofen, low molecular weight heparin, and doxycycline on the inhibition of corneal neovascularization. Cornea. 2006; 25(5)582–585
   PubMed Web of Science ®Google Scholar
• Riazi-Esfahani M, Peyman G A, Aydin E, Kazi A A, Kivilcim M, Sanders D R. Prevention of corneal neovascularization: Evaluation of various commercially available compounds in an experimental rat model. Cornea. 2006; 25(7)801–805
   PubMed Web of Science ®Google Scholar
• D'Amato R J, Loughnan M S, Flynn E, Folkman J. Thalidomide is an inhibitor of angiogenesis. Proc Natl Acad Sci USA. 1994; 91(9)4082–4085
   PubMed Web of Science ®Google Scholar
• Ashton N, Cook C, Langham M. Effect of cortisone on vascularization and opacification of the cornea induced by alloxan. Br J Ophthalmol. 1951; 35(11)718–724
   PubMed Web of Science ®Google Scholar
• Totan Y, Aydin E, Cekic O, et al. Effect of caffeic acid phenethyl ester on corneal neovascularization in rats. Curr Eye Res. 2001; 23(4)291–297
   PubMed Web of Science ®Google Scholar
• Donshik P C, Berman M B, Dohlman C H, Gage J, Rose J. Effect of topical corticosteroids on ulceration in alkali-burned corneas. Arch Ophthalmol. 1978; 96(11)2117–2120
   PubMedGoogle Scholar
• Lamparter S, Slight S H, Weber K T. Doxycycline and tissue repair in rats. J Lab Clin Med. 2002; 139(5)295–302
   PubMed Web of Science ®Google Scholar
• Folwarczna J, Janiec W, Firlus K, et al. Effects of doxycycline on the development of bone damage caused by prednisolone in rats. Pol J Pharmacol. 1999; 51(3)243–251
   PubMedGoogle Scholar
• Ramamurthy N S, Schroeder K L, McNamara T F, et al. Root-surface caries in rats and humans: Inhibition by a non-antimicrobial property of tetracyclines. Adv Dent Res. 1998; 12(2)43–50
   PubMedGoogle Scholar
• Ruiyuan S. Quantitative Pharmacology, 1st ed. People's Health Publishing House, Beijing 1987
   Google Scholar
• Perry H D, Hodes L W, Seedor J A, Donnenfeld E D, McNamara T F, Golub L M. Effect of doxycycline hyclate on corneal epithelial wound healing in the rabbit alkali-burn model. Preliminary observations. Cornea. 1993; 12(5)379–382
   PubMed Web of Science ®Google Scholar
• Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China. Chemical Industry Publishing Company, Beijing 2005
   Google Scholar
• Hanemaaijer R, Visser H, Koolwijk P, et al. Inhibition of MMP synthesis by doxycycline and chemically modified tetracyclines (CMTs) in human endothelial cells. Adv Dent Res. 1998; 12(2)114–118
   PubMedGoogle Scholar